TPRG1

gene
On this page

Also known as FLJ41238FLJ43694

Summary

TPRG1 (tumor protein p63 regulated 1, HGNC:24759) is a protein-coding gene on chromosome 3q28, encoding Tumor protein p63-regulated gene 1 protein (Q6ZUI0).

Predicted to be active in cytoplasm.

Source: NCBI Gene 285386 — RefSeq curated summary.

At a glance

  • GWAS associations: 7
  • Clinical variants (ClinVar): 43 total
  • MANE Select transcript: NM_198485

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24759
Approved symbolTPRG1
Nametumor protein p63 regulated 1
Location3q28
Locus typegene with protein product
StatusApproved
AliasesFLJ41238, FLJ43694
Ensembl geneENSG00000188001
Ensembl biotypeprotein_coding
Entrez285386

Gene structure

Transcript identifiers

Ensembl transcripts: 34 — 24 protein_coding, 10 protein_coding_CDS_not_defined

ENST00000345063, ENST00000412373, ENST00000425670, ENST00000433971, ENST00000456832, ENST00000460613, ENST00000464152, ENST00000473790, ENST00000479720, ENST00000481307, ENST00000485836, ENST00000488841, ENST00000493725, ENST00000496671, ENST00000497628, ENST00000867713, ENST00000867714, ENST00000867715, ENST00000867716, ENST00000867717, ENST00000867718, ENST00000867719, ENST00000867720, ENST00000867721, ENST00000867722, ENST00000867723, ENST00000867724, ENST00000949786, ENST00000949787, ENST00000949788, ENST00000949789, ENST00000949790, ENST00000949791, ENST00000949792

RefSeq mRNA: 1 — MANE Select: NM_198485 NM_198485

CCDS: CCDS3292

Canonical transcript exons

ENST00000345063 — 6 exons

ExonStartEnd
ENSE00001372486189238733189238909
ENSE00001389174189320626189325304
ENSE00001427712189171971189172131
ENSE00003593052189310386189310539
ENSE00003630174189207376189207594
ENSE00003789158189215292189215383

Expression profiles

Bgee: expression breadth ubiquitous, 208 present calls, max score 98.48.

FANTOM5 (CAGE): breadth broad, TPM avg 3.2370 / max 228.5142, expressed in 487 samples.

FANTOM5 promoters (20 alternative TSS)

Promoter IDTPM avgSamples expressed
405090.660638
405130.539383
404980.270361
404810.2516131
404820.173396
405110.166751
405000.156129
405010.144234
404970.139455
404800.103054

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370198.48gold quality
lower esophagus mucosaUBERON:003583497.83gold quality
esophagus squamous epitheliumUBERON:000692096.59gold quality
pharyngeal mucosaUBERON:000035595.19gold quality
oral cavityUBERON:000016794.93gold quality
upper leg skinUBERON:000426294.73gold quality
esophagus mucosaUBERON:000246993.97gold quality
skin of legUBERON:000151193.33gold quality
penisUBERON:000098992.37gold quality
zone of skinUBERON:000001492.27gold quality
skin of abdomenUBERON:000141692.20gold quality
upper arm skinUBERON:000426391.85gold quality
mammalian vulvaUBERON:000099791.52gold quality
vaginaUBERON:000099691.08gold quality
amniotic fluidUBERON:000017390.88gold quality
ectocervixUBERON:001224989.71gold quality
subcutaneous adipose tissueUBERON:000219089.09gold quality
right lobe of liverUBERON:000111488.68gold quality
gingivaUBERON:000182888.39gold quality
buccal mucosa cellCL:000233688.32gold quality
tendonUBERON:000004386.89gold quality
right uterine tubeUBERON:000130286.85gold quality
uterine cervixUBERON:000000286.80gold quality
gingival epitheliumUBERON:000194986.56gold quality
skin of hipUBERON:000155486.10gold quality
adipose tissueUBERON:000101385.14gold quality
body of tongueUBERON:001187684.93gold quality
granulocyteCL:000009484.81gold quality
endocervixUBERON:000045884.60gold quality
right lungUBERON:000216784.12gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes10.22
E-MTAB-7249no84.33

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): TP63

miRNA regulators (miRDB)

99 targeting TPRG1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-365899.9673.874379
HSA-MIR-651-3P99.9473.485177
HSA-MIR-515-5P99.9269.822343
HSA-MIR-519E-5P99.9269.622358
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-130599.9171.433443
HSA-MIR-374A-5P99.9071.342923
HSA-MIR-374B-5P99.9069.982734
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-132399.8369.892471
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-57799.7869.132479
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-4766-5P99.7569.232662
HSA-MIR-548O-3P99.7469.302228
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-6505-5P99.7369.251595
HSA-MIR-808499.7369.571760
HSA-MIR-132-3P99.7370.561424
HSA-MIR-212-3P99.7370.651424
HSA-MIR-120099.7170.421838

Literature-anchored findings (GeneRIF, showing 1)

  • Tumor protein P63 Regulated 1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating the NF-small ka, CyrillicB/cyclooxygenase-2/prostaglandin E2 axis. (PMID:34998360)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotprg1ENSDARG00000056026
mus_musculusTprg1ENSMUSG00000048399
rattus_norvegicusTprg1ENSRNOG00000063970

Paralogs (1): TPRG1L (ENSG00000158109)

Protein

Protein identifiers

Tumor protein p63-regulated gene 1 proteinQ6ZUI0 (reviewed: Q6ZUI0)

Alternative names: Protein FAM79B

All UniProt accessions (4): Q6ZUI0, C9IYC1, C9JDW1, H7C1G4

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Cytoplasm.

Tissue specificity. Expressed in the epidermal layer of the skin.

Similarity. Belongs to the TPRG1 family.

RefSeq proteins (1): NP_940887* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR022158Inositol_phosphataseDomain
IPR034753hSac2Domain
IPR040242TPRG1-likeFamily

Pfam: PF12456

UniProt features (4 total): chain 1, domain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZUI0-F173.900.34

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 71 (showing top): LEE_SP4_THYMOCYTE, TGACATY_UNKNOWN, MAF_Q6, CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP, CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN, VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP, LEE_RECENT_THYMIC_EMIGRANT, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ARID5B_TARGET_GENES, GREB1_TARGET_GENES, LHX9_TARGET_GENES, NFKBIA_TARGET_GENES, PBXIP1_TARGET_GENES, ZNF92_TARGET_GENES, MIR3658

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

560 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TPRG1TP63Q9H3D4490
TPRG1CFAP95Q5VTT2403
TPRG1ABHD14AQ9BUJ0371
TPRG1SACK1CQ9BQN1371
TPRG1SUSD1Q6UWL2366
TPRG1S100PBPQ96BU1354
TPRG1WDR6Q9NNW5348
TPRG1CBFA2T3O75081347
TPRG1EVA1CP58658347
TPRG1CCDC18Q5T9S5344
TPRG1FOXRED2Q8IWF2315
TPRG1C1orf162Q8NEQ5312
TPRG1TULP2O00295309
TPRG1PIP4K2AP48426306
TPRG1MEF2BQ02080296

IntAct

58 interactions, top by confidence:

ABTypeScore
TPRG1HSD17B13psi-mi:“MI:0915”(physical association)0.560
TPRG1APOC4psi-mi:“MI:0915”(physical association)0.560
TPRG1TMX2psi-mi:“MI:0915”(physical association)0.560
TPRG1RETREG3psi-mi:“MI:0915”(physical association)0.560
MFSD14BTPRG1psi-mi:“MI:0915”(physical association)0.560
APOC4TPRG1psi-mi:“MI:0915”(physical association)0.560
TPRG1SLC35C2psi-mi:“MI:0915”(physical association)0.560
APOC1TPRG1psi-mi:“MI:0915”(physical association)0.560
RHBDD2TPRG1psi-mi:“MI:0915”(physical association)0.560
TPRG1SCN3Bpsi-mi:“MI:0915”(physical association)0.560
TPRG1HSD17B11psi-mi:“MI:0915”(physical association)0.560
TPRG1REEP4psi-mi:“MI:0915”(physical association)0.560
EBAG9TPRG1psi-mi:“MI:0915”(physical association)0.560
TPRG1CIDEBpsi-mi:“MI:0915”(physical association)0.560
TPRG1CGRRF1psi-mi:“MI:0915”(physical association)0.560
TPRG1TMEM120Apsi-mi:“MI:0915”(physical association)0.560
SLC10A6TPRG1psi-mi:“MI:0915”(physical association)0.560
AQP6TPRG1psi-mi:“MI:0915”(physical association)0.560
TPRG1psi-mi:“MI:0915”(physical association)0.560
STX17A2ML1psi-mi:“MI:0914”(association)0.350
OR2A4A2ML1psi-mi:“MI:0914”(association)0.350
CCR1UBA6psi-mi:“MI:0914”(association)0.350
TPRG1RHBDD2psi-mi:“MI:0915”(physical association)0.000

BioGRID (23): TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TMEM120A (Two-hybrid)

ESM2 similar proteins: A0A1B7XV12, A0A571BF63, A0A5F8MPE6, A0JMA8, A3KQ58, A6NEN9, A6QNM3, A8E7C5, A8PJX4, B0W730, O00443, O00522, O59800, P70371, Q08AE8, Q0VA04, Q0VA42, Q14D04, Q16YA8, Q32LJ3, Q3V2K1, Q4R707, Q52KF3, Q5F3E8, Q5PQS3, Q5RAY1, Q5UQM6, Q5XIR8, Q61QK6, Q63ZP1, Q6C4Q6, Q6DTM3, Q6ING4, Q6NSI8, Q6S5J6, Q6TNJ1, Q6ZUI0, Q7Z3E5, Q7ZXG4, Q86VD1

Diamond homologs: A8WCF8, Q32LJ4, Q5T0D9, Q6ZUI0, Q8CB49, Q9DBS2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

43 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance37
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

4816 predictions. Top by Δscore:

VariantEffectΔscore
3:189207576:G:GTdonor_gain1.0000
3:189215384:G:GGdonor_gain1.0000
3:189238728:TATA:Tacceptor_loss1.0000
3:189238730:TAGGA:Tacceptor_loss1.0000
3:189238731:A:AGacceptor_gain1.0000
3:189238731:AG:Aacceptor_gain1.0000
3:189238731:AGGAT:Aacceptor_loss1.0000
3:189238732:G:GCacceptor_loss1.0000
3:189238732:G:GGacceptor_gain1.0000
3:189238732:GG:Gacceptor_gain1.0000
3:189238732:GGATA:Gacceptor_gain1.0000
3:189238905:GACAA:Gdonor_gain1.0000
3:189238909:AGT:Adonor_loss1.0000
3:189238910:G:GGdonor_gain1.0000
3:189238910:GTG:Gdonor_loss1.0000
3:189238911:TGA:Tdonor_loss1.0000
3:189238912:GAG:Gdonor_loss1.0000
3:189277108:G:GTdonor_gain1.0000
3:189320622:TCAGT:Tacceptor_loss1.0000
3:189320624:A:AGacceptor_gain1.0000
3:189320624:AGTT:Aacceptor_gain1.0000
3:189320625:G:GGacceptor_gain1.0000
3:189320625:GT:Gacceptor_gain1.0000
3:189320625:GTT:Gacceptor_gain1.0000
3:189320625:GTTG:Gacceptor_gain1.0000
3:189320625:GTTGT:Gacceptor_gain1.0000
3:189123567:A:AGacceptor_gain0.9900
3:189123568:A:Gacceptor_gain0.9900
3:189123570:A:AGacceptor_gain0.9900
3:189123571:A:Gacceptor_gain0.9900

AlphaMissense

1796 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:189310450:T:AW182R0.987
3:189310450:T:CW182R0.987
3:189320815:T:CF275L0.987
3:189320817:T:AF275L0.987
3:189320817:T:GF275L0.987
3:189238743:T:AW105R0.979
3:189238743:T:CW105R0.979
3:189238748:C:AN106K0.978
3:189238748:C:GN106K0.978
3:189207583:T:CF67L0.977
3:189207585:T:AF67L0.977
3:189207585:T:GF67L0.977
3:189215311:C:AA77D0.976
3:189310487:T:CF194S0.973
3:189238759:A:TE110V0.969
3:189238882:T:CF151S0.969
3:189238789:T:CL120P0.968
3:189310496:A:GH197R0.967
3:189310497:T:AH197Q0.967
3:189310497:T:GH197Q0.967
3:189238747:A:TN106I0.964
3:189238745:G:CW105C0.963
3:189238745:G:TW105C0.963
3:189238804:A:CY125S0.963
3:189320816:T:CF275S0.963
3:189207593:G:CR70P0.962
3:189238803:T:GY125D0.962
3:189310403:T:CL166P0.959
3:189320788:T:GY266D0.959
3:189320800:C:AR270S0.959

dbSNP variants (sampled 300 via entrez): RS1000003247 (3:189295775 T>C), RS1000008947 (3:189276681 A>G), RS1000009433 (3:189146984 C>T), RS1000056188 (3:189294570 A>T), RS1000059958 (3:189276970 A>C), RS1000066234 (3:189162762 T>TG), RS1000073274 (3:189297106 G>A), RS1000076468 (3:189078295 G>A), RS1000086935 (3:189150469 C>A,T), RS1000093997 (3:189162466 A>T), RS1000097212 (3:189229868 G>A,T), RS1000106698 (3:188997367 C>T), RS1000110405 (3:189123665 C>G), RS1000119717 (3:189271540 A>G), RS1000126407 (3:189064900 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST002115_8Axial length3.000000e-07
GCST003327_8Squamous cell carcinoma1.000000e-11
GCST003479_2Hair color3.000000e-06
GCST006409_20Allergic rhinitis2.000000e-13
GCST009798_88Asthma5.000000e-11
GCST010148_6Cutaneous squamous cell carcinoma6.000000e-15
GCST012490_365Femur bone mineral density x serum urate levels interaction3.000000e-12

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005318axial length measurement
EFO:1001927cutaneous squamous cell carcinoma
EFO:0004531urate measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

18 total (human), top 18 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression, increases expression3
methyleugenoldecreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases methylation1
sodium arsenatedecreases expression, increases abundance1
3,4-dichloroanilinedecreases expression1
sodium arseniteincreases expression1
hydroquinoneincreases expression1
abrineincreases expression1
bisphenol Sdecreases expression1
(+)-JQ1 compoundincreases expression1
Fulvestrantincreases methylation1
Arsenicdecreases expression, increases abundance1
Estradiolaffects cotreatment, decreases expression1
N-Nitrosopyrrolidinedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1decreases methylation1
Okadaic Aciddecreases expression1

Cellosaurus cell lines

1 cell lines: 1 finite cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B4GJWG4066Finite cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): allergic rhinitis, squamous cell carcinoma